Morgan Stanley’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $609M | Buy |
11,030,651
+5,201,988
| +89% | +$282M | 0.04% | 465 |
|
|
2025
Q4 | $286M | Buy |
5,828,663
+879,435
| +18% | +$41M | 0.02% | 758 |
|
|
2025
Q3 | $214M | Sell |
4,949,228
-225,027
| -4% | -$8.79M | 0.01% | 891 |
|
|
2025
Q2 | $199M | Sell |
5,174,255
-141,267
| -3% | -$5.4M | 0.01% | 883 |
|
|
2025
Q1 | $206M | Sell |
5,315,522
-411,472
| -7% | -$15.1M | 0.01% | 831 |
|
|
2024
Q4 | $194M | Sell |
5,726,994
-2,226,839
| -28% | -$80.2M | 0.01% | 849 |
|
|
2024
Q3 | $325M | Sell |
7,953,833
-2,154,686
| -21% | -$88.1M | 0.02% | 616 |
|
|
2024
Q2 | $389M | Sell |
10,108,519
-2,362,518
| -19% | -$99.4M | 0.03% | 535 |
|
|
2024
Q1 | $535M | Sell |
12,471,037
-4,633,309
| -27% | -$191M | 0.04% | 419 |
|
|
2023
Q4 | $634M | Buy |
17,104,346
+9,552,791
| +127% | +$343M | 0.03% | 575 |
|
|
2023
Q3 | $274M | Buy |
7,551,555
+156,480
| +2% | +$5.55M | 0.03% | 583 |
|
|
2023
Q2 | $264M | Buy |
7,395,075
+1,788,975
| +32% | +$64.2M | 0.03% | 611 |
|
|
2023
Q1 | $199M | Buy |
5,606,100
+499,906
| +10% | +$17.5M | 0.02% | 698 |
|
|
2022
Q4 | $179M | Buy |
5,106,194
+75,145
| +1% | +$2.5M | 0.02% | 726 |
|
|
2022
Q3 | $148M | Sell |
5,031,049
-1,210,251
| -19% | -$45.9M | 0.02% | 705 |
|
|
2022
Q2 | $340M | Buy |
6,241,300
+2,869,438
| +85% | +$158M | 0.04% | 404 |
|
|
2022
Q1 | $184M | Sell |
3,371,862
-76,798
| -2% | -$4.17M | 0.02% | 565 |
|
|
2021
Q4 | $190M | Buy |
3,448,660
+38,838
| +1% | +$2.02M | 0.02% | 588 |
|
|
2021
Q3 | $163M | Buy |
3,409,822
+30,181
| +0.9% | +$1.52M | 0.02% | 610 |
|
|
2021
Q2 | $168M | Buy |
3,379,641
+189,144
| +6% | +$9.09M | 0.02% | 612 |
|
|
2021
Q1 | $142M | Buy |
3,190,497
+155,078
| +5% | +$7.04M | 0.02% | 612 |
|
|
2020
Q4 | $140M | Buy |
3,035,419
+333,325
| +12% | +$15.3M | 0.02% | 587 |
|
|
2020
Q3 | $127M | Buy |
2,702,094
+63,742
| +2% | +$3.19M | 0.02% | 510 |
|
|
2020
Q2 | $135M | Sell |
2,638,352
-964,288
| -27% | -$49.5M | 0.03% | 458 |
|
|
2020
Q1 | $171M | Buy |
3,602,640
+897,779
| +33% | +$47.9M | 0.05% | 343 |
|
|
2019
Q4 | $159M | Sell |
2,704,861
-64,146
| -2% | -$3.57M | 0.04% | 444 |
|
|
2019
Q3 | $148M | Sell |
2,769,007
-307,699
| -10% | -$15.8M | 0.04% | 434 |
|
|
2019
Q2 | $154M | Buy |
3,076,706
+169,733
| +6% | +$8.52M | 0.04% | 417 |
|
|
2019
Q1 | $152M | Buy |
2,906,973
+368,893
| +15% | +$18.4M | 0.04% | 404 |
|
|
2018
Q4 | $121M | Sell |
2,538,080
-832,234
| -25% | -$41M | 0.04% | 458 |
|
|
2018
Q3 | $169M | Buy |
3,370,314
+477,894
| +17% | +$24.3M | 0.04% | 405 |
|
|
2018
Q2 | $146M | Buy |
2,892,420
+473,618
| +20% | +$23.9M | 0.04% | 432 |
|
|
2018
Q1 | $118M | Buy |
2,418,802
+177,352
| +8% | +$8.26M | 0.03% | 507 |
|
|
2017
Q4 | $99.4M | Sell |
2,241,450
-826,306
| -27% | -$38.2M | 0.03% | 596 |
|
|
2017
Q3 | $156M | Sell |
3,067,756
-279,784
| -8% | -$14.2M | 0.05% | 389 |
|
|
2017
Q2 | $180M | Buy |
3,347,540
+84,932
| +3% | +$4.53M | 0.05% | 360 |
|
|
2017
Q1 | $172M | Sell |
3,262,608
-428,826
| -12% | -$21.8M | 0.05% | 366 |
|
|
2016
Q4 | $178M | Buy |
3,691,434
+78,976
| +2% | +$3.9M | 0.06% | 345 |
|
|
2016
Q3 | $195M | Sell |
3,612,458
-67,215
| -2% | -$3.69M | 0.07% | 322 |
|
|
2016
Q2 | $199M | Buy |
3,679,673
+108,123
| +3% | +$5.7M | 0.07% | 303 |
|
|
2016
Q1 | $181M | Sell |
3,571,550
-300,304
| -8% | -$15M | 0.07% | 312 |
|
|
2015
Q4 | $195M | Buy |
3,871,854
+213,390
| +6% | +$10.9M | 0.07% | 295 |
|
|
2015
Q3 | $176M | Sell |
3,658,464
-526,312
| -13% | -$27.4M | 0.07% | 321 |
|
|
2015
Q2 | $218M | Buy |
4,184,776
+330,799
| +9% | +$18.6M | 0.08% | 292 |
|
|
2015
Q1 | $222M | Buy |
3,853,977
+508,807
| +15% | +$29.2M | 0.08% | 276 |
|
|
2014
Q4 | $179M | Sell |
3,345,170
-109,883
| -3% | -$6.15M | 0.07% | 321 |
|
|
2014
Q3 | $199M | Buy |
3,455,053
+964,811
| +39% | +$59.1M | 0.08% | 286 |
|
|
2014
Q2 | $166M | Buy |
2,490,242
+170,735
| +7% | +$11.6M | 0.07% | 331 |
|
|
2014
Q1 | $155M | Sell |
2,319,507
-236,144
| -9% | -$16M | 0.06% | 333 |
|
|
2013
Q4 | $171M | Buy |
2,555,651
+301,971
| +13% | +$19.6M | 0.07% | 305 |
|
|
2013
Q3 | $141M | Buy |
2,253,680
+57,136
| +3% | +$3.68M | 0.07% | 337 |
|
|
2013
Q2 | $137M | Buy |
+2,196,544
| New | +$139M | 0.07% | 321 |
|
Other funds holding GSK
JEST
Morgan Stanley's GSK Position: Q1 2026 in Review
Morgan Stanley increased its GSK (GSK) stake by 89% in Q1 2026, buying an estimated $282M and bringing the position to 11,030,651 shares worth $609M. The position accounts for 0.04% of the portfolio, ranked #465.
Morgan Stanley first reported a position in GSK in Q2 2013 and has held it in 52 quarters since. The position peaked at $634M in Q4 2023. 1,031 funds tracked by Wall St. Rank hold GSK as of Q1 2026.
- Morgan Stanley held 11,030,651 shares of GSK worth $609M as of Q1 2026.
- Morgan Stanley bought 5,201,988 GSK shares in Q1 2026, an estimated $282M.
- GSK made up 0.04% of Morgan Stanley's portfolio in Q1 2026, its #465 holding.
- Morgan Stanley first reported a position in GSK in Q2 2013 and has held it in 52 quarters since.
- Morgan Stanley's GSK position peaked at $634M in Q4 2023.
- 1,031 funds tracked by Wall St. Rank held GSK as of Q1 2026.
Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.